1
|
Kleinmann N, Wirth G, Lin JS, Matin SF, Nativ O, Mayer G, Witjes JA, Shvero A, Chamie K, Pantuck AJ, Smith A, Schoenberg M, Malchi N, Hakim G, Agmon-Gerstein Y, Jeshurun-Gutshtat M, Klein I, Kopelen H, Lerner SP. Thermo Reversible Hydrogel Based Delivery of Mitomycin C (UGN-101) for Treatment of Upper Tract Urothelial Carcinoma (UTUC). Bladder Cancer 2019. [DOI: 10.3233/blc-180182] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
| | | | - Jeffrey S. Lin
- Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
| | | | - Ofer Nativ
- Benai-Zion Medical Center, Haifa, Israel
| | - Gil Mayer
- Benai-Zion Medical Center, Haifa, Israel
| | | | - Asaf Shvero
- Chaim Sheba Medical Center, Tel-Hashomer, Israel
| | | | | | | | - Mark Schoenberg
- The Montefiore Medical Center and The Albert Einstein College of Medicine, Bronx, NY, USA
- UroGen, Pharma Ltd., Ra’anana, Israel
| | | | - Gil Hakim
- UroGen, Pharma Ltd., Ra’anana, Israel
| | | | | | | | - Helen Kopelen
- Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
| | - Seth P. Lerner
- Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|